Propranolol Dosing for Esophageal Varices
Start propranolol at 20-40 mg orally twice daily and titrate every 2-3 days until achieving a resting heart rate of 55-60 beats per minute, with a maximum dose of 320 mg/day in patients without ascites or 160 mg/day in patients with ascites. 1
Initial Dosing and Titration Schedule
The AASLD 2017 guidelines provide clear, evidence-based dosing parameters 1:
- Starting dose: 20-40 mg orally twice daily
- Titration interval: Adjust every 2-3 days
- Target goal: Resting heart rate of 55-60 beats per minute
- Blood pressure safety threshold: Systolic blood pressure should not decrease below 90 mmHg
Maximum Dose Considerations
The maximum daily dose depends critically on the presence of ascites 1, 2:
- Without ascites: 320 mg/day maximum
- With ascites: 160 mg/day maximum (50% reduction)
This distinction is crucial because patients with ascites have compromised hemodynamics and are at higher risk for adverse effects from beta-blockade.
Treatment Goals and Monitoring
Primary endpoint: Achieve target heart rate of 55-60 bpm rather than a specific dose 1. This heart rate-guided approach is superior to fixed dosing because hemodynamic response varies significantly between patients.
Recent evidence suggests that lower doses may be equally effective with better tolerability. A 2019 study found no dose-dependent hemodynamic benefit when escalating from 80 to 120 mg/day, with significantly more adverse events at higher doses (30% vs 6.9% requiring reduction/discontinuation) 3. This supports titrating to clinical effect rather than automatically pushing to maximum doses.
Context-Specific Dosing
Primary Prophylaxis (Never Bled)
Use the standard titration protocol above for patients with medium or large varices 1. Propranolol is equally effective as nadolol or carvedilol, though a 2025 meta-analysis suggests EVL may be slightly superior to propranolol specifically (though not necessarily to other NSBBs) 4.
Secondary Prophylaxis (Post-Bleeding)
Same dosing schedule applies, but propranolol should be combined with endoscopic variceal ligation (EVL) 1. Monotherapy with propranolol alone is insufficient after a bleeding episode.
Critical Caveats and Contraindications
Significant ascites (≥grade 2): Exercise extreme caution or avoid NSBBs entirely. A 2020 propensity-matched study showed significantly higher all-cause mortality (48.9% vs 31.2%) and hepatic failure deaths (40.5% vs 20.0%) when propranolol was added to EVL in patients with significant ascites 5. In these patients, EVL alone may be preferable.
Refractory ascites or spontaneous bacterial peritonitis: The role of NSBBs remains controversial 2. If used, employ thorough monitoring of blood pressure and renal function with consideration of lower doses (e.g., 80 mg/day maximum).
Absolute contraindications 2:
- Sinus bradycardia
- Second- or third-degree AV block
- Decompensated heart failure
- Severe obstructive pulmonary disease
- Peripheral arterial insufficiency
Common Side Effects Requiring Dose Adjustment
Approximately 15% of patients require dose reduction or discontinuation 2. Monitor for:
- Dizziness, fatigue, general weakness
- Dyspnea
- Hypotension (systolic <90 mmHg)
- Bradycardia (<55 bpm at rest)
- Erectile dysfunction
Important: Never abruptly discontinue propranolol, as this increases risk of variceal bleeding and mortality 2. Taper gradually over several weeks if discontinuation is necessary.
Long-Term Management
Continue propranolol indefinitely once started 2. Unlike EVL, patients on NSBBs for primary prophylaxis do not require serial surveillance endoscopies 1, which is a significant practical advantage.